Belgium
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 5.80 B
|
Dec. 31, 2023 | USD 194.45 | 1.55% |
|
Belgium |
|
2 |
USD 842.15 M
|
Dec. 31, 2023 | USD 19.73 | 0.25% |
|
Belgium |
|
3 |
USD 264.60 M
|
Dec. 31, 2023 | USD 22.74 | -0.48% |
|
Belgium |
|
4 |
USD 70.19 M
|
Dec. 31, 2023 | USD 1.91 | 0.00% |
|
Belgium |
|
5 |
USD 4.80 M
|
Dec. 31, 2023 | USD 10.80 | 2.86% |
|
Belgium |
|
6 |
USD 786.06 K
|
Dec. 31, 2023 | USD 2.24 | -2.03% |
|
Belgium |
The Healthcare company in Belgium with the highest Revenue is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 5.80 B.
The Healthcare company in Belgium with the lowest Revenue is Sequana Medical NV (Brussels Stock Exchange: SEQUA.BR) at USD 786.06 K.
The top 10 Healthcare companies in Belgium by Revenue are UCB SA, Fagron NV, Galapagos NV, MDxHealth SA, Nyxoah S.A. and Sequana Medical NV.
The bottom 10 Healthcare companies in Belgium by Revenue are Sequana Medical NV, Nyxoah S.A., MDxHealth SA, Galapagos NV, Fagron NV and UCB SA.